期刊文献+

门冬氨酸鸟氨酸在肝细胞癌肝动脉介入栓塞前后护肝作用的临床观察 被引量:2

Clinical study of L-ornithine-L-aspartate on the protective liver function in the management of primary hepatic carcinoma treated by TACE
下载PDF
导出
摘要 目的探讨对肝癌病人进行介入栓塞治疗前后给予门冬氨酸鸟氨酸的护肝作用。方法选择经B超、CT、AFP等明确诊断为肝癌并且已为中晚期而不宜手术治疗的病人为研究对象,在对其进行肝动脉化疗和栓塞(TACE)治疗前后给予门冬氨酸鸟氨酸治疗13天。并设立对照组,通过生化检测观察介入治疗同时给予门冬氨酸鸟氨酸治疗的肝功能改变。结果门冬氨酸鸟氨酸对介入治疗的肝癌病人的肝功能有明显的保护作用,病人介入后丙氨酸转氨酶、天冬氨酸转氨酶和胆红素有所升高,但能较快恢复正常。结论门冬氨酸鸟氨酸可以防治介入栓塞导致的肝癌病人肝功能的进一步损害,保护和促进肝功能恢复,减少并发症,增加对介入治疗的耐受性。 Objective To explore the protective effect of L-omithine-L-aspartate on the liver function damage induced by TACE. Methods Unresectable primary hepatic carcinoma patients entered into research group A. They were injected by 10g L-ornithine-L-asparrate daily for 3 days before TACE and for 10 days after TACE. Liver function was observed to evaluate the effect of L-ornithine-L-aspartate. Results L-ornithine-L-aspartate had an active protective effect in PHC patients. Compared with control group B, there was a statistical significant change. Conclusion L-ornithine-L-aspartate can prevent the liver function from damage in PHC patients caused by TACE.
出处 《实用肝脏病杂志》 CAS 2005年第6期343-345,共3页 Journal of Practical Hepatology
关键词 肝细胞癌 门冬氨酸鸟氨酸 肝动脉介入栓塞 Hepatoma, L- ornithine- L- aspartate, TACE
  • 相关文献

参考文献7

  • 1吕毅,潘承恩,王居,孟令忠.肝癌化疗栓塞术后综合征发生机理及治疗[J].肝胆外科杂志,1995,3(3):137-139. 被引量:10
  • 2Inoue H. Treatment of liver metastases by arterial injection of adriamycin/mitomyein C lipiodol suspension.Aeta Radiologiea, 1991,11:225
  • 3郑传胜,冯敢生,黄群.肝动脉化疗、栓塞损害肝功能的临床研究[J].临床消化病杂志,1996,8(3):112-115. 被引量:28
  • 4Delcker A, Turowski B, Mihm U, et al. Proton MR spectroscopy of neurometabolites in hepatitic encephalopathy during L-ornithine-L-aspartate treatment: results of a pilot study. Metab Brain Dis, 2002,17(2) :103 - 11
  • 5Rose C, Michalak A, Pannunzio P, et a!. L-omithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action. Metab Dis, 1998,13(2)147 -57
  • 6Scheller A, Jacob U, Keilhauer R, et al. Verbessenmg der zytostatikatoleranz durch ornithinaspartal. Der Bayrische Internist 1998,1:54-60
  • 7Kleef R, Scheller A. L-omithine-L-aspartate-a rationale for its use in combination with chemotherapy, radiation, and hyperthermia in oncology. Forsch Komplementarmed, 1999,6(4) : 216 - 230

二级参考文献2

  • 1Per-Olof Hasselgren,鲁泽清.肝缺血时肝细胞损伤的预防和治疗[J]国外医学外科学分册,1987(05).
  • 2杨继恒,党正祥,.肠道屏障的损伤及保护[J].中国医师进修杂志,1993,0(8):28-30. 被引量:3

共引文献30

同被引文献27

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部